Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Acinetobacter, aeruginosa, ahead, annua, assessment, baumannii, Biomolecular, Enterobacter, ESKAPE, faecium, FIU, intramuscular, Jansen, Klebsiella, Medical, mutual, mutually, order, pneumoniae, pre, premium, renewed, spp, title, variety
Removed:
accounted, achieved, agency, anniversary, API, applied, assignee, biotechnology, care, clarify, clinically, Clostridium, colony, compound, concentration, consummated, contrast, decreased, demonstrated, designated, diarrhea, difficile, divested, efficacy, equivalent, evaluated, exhibited, extinguish, field, forming, generation, genetically, inhibitory, jurisdiction, LLC, manufacturability, measurable, MIC, opted, plasmid, positive, promising, purification, pursued, pursuit, receivable, reduced, reducing, relapse, relation, relevant, remaining, reorganization, select, selected, showed, sought, stability, standard, sublicense, subscription, survival, toxicity, toxin, TS, vancomycin
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view